SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

🔥 COCK Token – The Ultimate Cross-Chain MemeFi Powerhouse 🔥  In just under 20 days, $COCK has smashed expectations, broken ATHs, and built a project that’s shaking up Cardano and the entire crypto space. 🐓 What Makes $COCK Special?      The Name: Love it or hate it, the energy and engagement it generates are undeniable. The nuance in language and wild appeal set us apart.     #MEMEFI Pioneer: We’re not just another meme coin. $COCK is leading a movement by combining DeFi mechanics, game theory, and community engagement into a groundbreaking ecosystem.     COCKARENA: At the core of our ecosystem is the COCKARENA, a PvP HODL game. Players battle it out, and early exit fees fuel redistributions, burns, and the treasury. This ensures price appreciation and long-term sustainability for loyal holders.  🎰 The COCK Casino  Our casino isn’t just fun—it’s a serious revenue stream for the FLOCK.      Games: Bonanza, Crash, Blackjack, and Roulette (coming soon!).     Impact: Over 7,834 ADA in profits generated within days, directly supporting rewards, burns, and reinvestment.  💰 COCK-ARENA Loans  Unlock liquidity without selling your tokens.      Loan Terms: Borrow up to 30% of your holdings while continuing to earn rewards in the arena.     Investor Focus: Perfect for savvy investors staying in the game while tapping into their holdings.  🤝 Our Insane Partnerships  We’re bridging gaps, building alliances, and breaking barriers across the crypto space. Key Partners:      DANZO: Powering #MEMEFI with Arena, Casino, and Loans.     KLENEK: Interactive training room.     HSKN (Charles Hoskilien): Supporting and starting COCKPIN with 115 AIR NODES for DePIN aggregation. Plans to add APEX and Earth Nodes through a crypto company incorporated in Costa Rica.     ELITE CATS / SNEKKIES / HOT / BANK: Rewarding NFT holders with COCK-LOCK tokens and vice versa.     OCKZ: COCKSOCKS, Golden Cock Ticket (1M COCK), airdrop rewards, and whitelist perks for holders of 200 ADA worth of $COCK.     OLI Partnership:         Content Creation: Lux and the team are crafting engaging educational content about memes and MemeFi for OLi's platform.         Strategic Investment: The OLi Community Trust will invest in $COCK, distributing 100% of rewards to $OLI holders.         Community Reach: Over 22,000 learners will discover $COCK through OLi's gamified ecosystem.     Hi-Rez the Rapper: Expanding reach in marketing and entertainment.     KUNO, CALEB, CADEN, FITY, ROVER, WhaleInsider: Influential collaborators driving crypto adoption and growth.     Cardano Girls: Helping us understand and communicate effectively with ADA’s female audience.     WallStreetBets: Breaking barriers and increasing engagement.     Antonio Brown: Endorsing, supporting, and even playing in the casino and arena!     Advisors:         BERIS, HECKTHESNEK, RTB, CRYPTOGENIUS: Trusted names advising and supporting the project.  Future Partnerships:  More collaborations are in the pipeline to continue expanding engagement and bring new eyes to ADA and CNTs. 🔥 Unmatched Results in Just 20 Days      Supply Burned: 1.65%, worth 148K ADA!     Arena Fees Collected: 54M COCK, worth over 500K ADA, fueling rewards, burns, and partnerships.     Staked COCK-LOCK: 11M COCK-LOCK in the liquid staking platform, with more coming.     Casino Revenue: Skyrocketing profits directly rewarding holders and growing the treasury.     Top Blast Contests: Generated over 120K ADA in volume, rewarding participants with over 50K ADA in prizes.  🌍 Our Vision  To be the most decentralized, rewarding, and innovative token on Cardano while fostering cross-chain collaboration and onboarding the masses.      Breaking Barriers: We’re bringing BTC, ETH, SOL, and other chains into the fold.     Community-Driven: Focused on building bridges and showcasing that crypto can be fun, rewarding, and sustainable.     Expansion: This is just the beginning. With more burns, rewards, and partnerships on the way, $COCK is set to redefine what’s possible in the MemeFi space.  💎 Time in the arena > Timing the market. The FLOCK is unstoppable. Let’s keep breaking walls for Cardano and onboard new users as we take $COCK to new heights.

CockCardano

$COCK.X is trending due to the launch of Cocky Wings LLC, a real-world business selling chicken wings, which aims to drive revenue for token buybacks. The community is excited about the potential of a meme coin with real-world utility, with many highlighting the connection to the Cardano chain ($ADA.X).

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as its community rallies around its fair launch and Bitcoin-native nature, contrasting it with other meme coins. Community members are actively discussing its potential to outperform Dogecoin and its strong connection to the Bitcoin network. There's also excitement surrounding potential exchange listings and the involvement of C2 Blockchain.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as community members rally behind this Bitcoin memecoin, touting its fair launch and strong community as key differentiators. Some believe that $DOG could flip DOGE, with many citing its decentralization as a major advantage. The community is actively coordinating buys and sharing information on how to acquire the token.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending due to speculation around a potential licensing deal with AstraZeneca and positive momentum from its lung cancer drug, Ivonescimab, currently in Phase III trials. Community discussions revolve around the drug's efficacy, trial data, and the possibility of a buyout, with some skepticism about the company's valuation in the absence of FDA approval. The stock's volatile price action and high short interest are also fueling discussions among investors.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

Volt (XVM.X) is trending as community members discuss its potential integration with the XRP ledger for tokenizing real-world assets (RWA). The recent launch and relatively low market cap are generating excitement, with many highlighting it as an early opportunity in the RWA space. However, some users are also expressing concerns about where to purchase the token and whether it is a legitimate project.

This isn’t just another token. $RISK is a symbol, a call to the fearless, the dream-chasers, the ones who know that greatness only comes to those who are willing to leap.  Born from the legendary phrase “risk it for the biscuit,” $RISK is a tribute to boldness. It’s made for those who refuse to settle, who thrive on high-stakes moments, and who would rather go all in than live with the regret of playing it safe.  In the world of $RISK, there are no participation trophies. You either take the shot or you miss the opportunity.  This token represents a lifestyle, the mindset that: 	•	Playing it safe never made legends. 	•	Caution doesn’t make history. 	•	Only the bold get rewarded.

ItForTheBiscuit

ItForTheBiscuit (RISK.X) is trending amid community excitement surrounding its team and potential for significant growth. Bullish sentiment is fueled by perceived strong community support and positive technical analysis, with some anticipating a parabolic pump. The project's ecosystem and creator fees are also sparking interest.

Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Precipio Inc

Precipio (PRPO) is trending as investors discuss the company's revenue growth and potential for a breakout moment, fueled by news of increased revenue and decreased cash burn. Community members are pointing to bullish chart patterns and the stock's low float, with some speculating about a possible buyout. The attention comes amid optimism around the company's financials and its pursuit of profitability.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending with its community rallying around upcoming staking features and ongoing development efforts. The community is actively promoting the coin's strong performance relative to other cryptos and highlighting its engaged developer. Many are also excited about a planned token burn event.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

Fueled by news of a land sale agreement potentially boosting NAV, Gyrodyne is trending as traders discuss its low float and potential for a significant squeeze. Community members are closely watching key breakout levels, anticipating a rapid price increase if momentum continues. The stock's historical volatility and potential for a meme-driven rally are also contributing to the current buzz.

"Founded by OS expert Rong Chen, Elastos is building the blockchain industry’s most comprehensive and interoperable open source platform. Using a hybrid consensus that combines the secure hashpower of Bitcoin and the democratic ideals of Delegated-Proof-of-Stake, the SmartWeb of Elastos is a suite of software for an entirely decentralized internet. Elastos employs not only blockchain technology, but a peer-to-peer network for communication, decentralized data storage services, and a decentralized ID (DID) system for all digital assets. With sidechains like Ethereum, Elastos is not merely the foundation for securing truly decentralized applications that can scale, it is the foundation for true data ownership.   elastOS, the flagship product of the Elastos Smartweb, brings the entire decentralized ecosystem into a single App, currently available for Android and in development for both iOS and desktop.  Elastos is also actively searching for both new and existing dApp projects through its Cyber Republic initiative. Cyber Republic possesses a community-governed grant fund designed to help startups and existing businesses explore blockchain. You can read more about Cyber Republic at https://www.cyberrepublic.org.

Elastos

Elastos is trending as community members discuss its potential as a Bitcoin Layer 2 solution and speculate on future price movements, with some anticipating a significant run. Recent integration news and its limited token supply are also fueling interest. However, some traders are wary of its historical price action and dependence on broader market trends.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36.&nbsp;The analysts&nbsp;revised their view following Baxter’s weak&nbsp;second-quarter (Q2) results, which also included a trimmed 2025 outlook and a cautious commentary on 2026 growth.Adjusted earnings for the quarter were $0.59 per share, which missed the $0.61 consensus. Revenue of $2.81 billion slightly missed the $2.82 billion estimate. Baxter’s full-year guidance was also narrowed to $2.42 to $2.52 from $2.47 to $2.55.CFO Joel Grade pointed to ongoing softness in demand for IV fluids, which are used to deliver medications or nutrients directly into a patient’s bloodstream, as a major drag on performance. "While we never want to lower expectations, our overall objective is reducing the outlook to capture more of the potential downside risks."That softness stems from conservation practices implemented after Hurricane Helene damaged Baxter’s North Carolina production facility in 2024.&nbsp;While supply has since recovered, the company expects demand to remain about 20% below normal levels for the rest of 2025, which will continue to weigh on operating income and profit per share.Stifel noted that Baxter’s disappointing Q2 results, lowered full-year guidance, and 2026 outlook have left the firm “feeling that the path to reliably-consistent mid-single-digit sales growth and more-meaningful margin expansion could take longer than previously thought.”Additional pressure came from Baxter’s pharmaceuticals segment, where injectable drug sales declined 1% and anesthesia sales dropped by low double digits globally.&nbsp;The company also voluntarily halted shipments of its Novum IQ Large Volume Pump following reports of two deaths and multiple injuries.On the positive side, Baxter lowered its projected tariff impact for 2025 to $40 million, down from a previous estimate of $60 million to $70 million.Andrew Hider is set to take over as CEO in early September.On Stocktwits, retail sentiment for Baxter was ‘extremely bullish’ amid ‘high’ message volume.One user on Stocktwits&nbsp;opined that Baxter is a profitable company with potential tailwinds over the next six months.&nbsp;<stembedurl>https://stocktwits.com/Philholl/message/623509381</stembedurl>Another user said that they started a position in the stock, calling it “way oversold” following what they viewed as a minor earnings miss, adding that healthcare stocks have been under pressure lately but don’t expect that trend to last.<stembedurl>https://stocktwits.com/Dr_Van_Nostrend/message/623270580</stembedurl><a href="https://stocktwits.com/symbol/BAX">Baxter’s stock</a> has declined 25% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Baxter International logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Baxter Downgraded By Stifel On Soft Q2, Guidance Cut — But Retail Eyes A Rebound

Stifel warned that Baxter’s path to consistent growth and margin expansion may take longer than expected, pointing to a cautious 2026 outlook.

Equity

Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates

Baxter (BAX) delivered earnings and revenue surprises of -1.67% and -0.28%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down

Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.

Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics

Besides Wall Street's top-and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.

InMode (INMD) Q2 Earnings and Revenues Beat Estimates

InMode (INMD) delivered earnings and revenue surprises of +9.30% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?

BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.

Shares of Baxter International Inc. (BAX) fell over 2% on Monday morning after the medtech company announced that it has appointed Andrew Hider as president and chief executive officer.Hider will take up his responsibilities no later than Sept. 3 or at an earlier date after completing his current commitments at ATS Corporation (ATS), the company said. Hider has been serving as CEO of ATS, who providers automation solutions for companies including in the life sciences, food and beverage, and consumer products industries, since 2017.Prior to joining ATS, Hider served as president and CEO of the Taylor Made Group, LLC, and served in several leaderships roles at life sciences and diagnostics company Danaher Corporation.<a href="https://stocktwits.com/symbol/BAX">Baxter</a> has been without a permanent CEO since February when José E Almeida retired from his executive roles, including that of the CEO. Since then, Brent Shafer has been serving as chair and interim CEO of the company.Shafer will now transition to independent chair of the Baxter Board, the company said.In the first quarter of 2025, Baxter’s worldwide sales from continuing operations totalled about $2.63 billion, marking a growth of 5% year-on-year, after production at its North Cove manufacturing site was disrupted to the second half of 2024 following a flooding event caused by Hurricane Helene.In May, the company said that its inventory levels are restored.Net income per diluted share for the quarter came in at $0.55, on top of the company’s original guidance.The company also divested its kidney care business to investment firm Carlyle in January for $3.8 billion.On Stocktwits, retail sentiment around Baxter fell from ‘neutral’ to ‘bearish’ territory over the past 24 hours while message volume remained at ‘high’ levels.<figure class="image"><img style="aspect-ratio:628/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_07_at_11_19_00_AM_png_35e8069f75.webp" alt="BAX's Sentiment Meter and Message Volume as of 11:20 a.m. ET on July 7, 2025 | Source: Stocktwits" width="628" height="64"><figcaption>BAX's Sentiment Meter and Message Volume as of 11:20 a.m. ET on July 7, 2025 | Source: Stocktwits</figcaption></figure>BAX stock is up by about 4% this year but down by about 10% over the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/scott-bessent-to-meet-china-next-two-weeks/chFtFuwR5ft">Treasury Secretary Scott Bessent Says He Will Meet His Chinese Counterpart In The Next Two Weeks: ‘There Are Things For Us To Do Together’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Baxter Appoints Andrew Hider To Succeed Jose Almeida As CEO: Retail Sentiment Falters

Hider will take up his responsibilities no later than Sept. 3 or at an earlier date after completing his current commitments at ATS Corporation (ATS), Baxter said.

FMS Stock Likely to Gain on New Optimization Plan FME Reignite

Fresenius Medical Care unveils FME Reignite, targeting one billion euros in cost savings, tech upgrades and enhanced shareholder returns.

BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad

Baxter International, Inc. engages in the provision of a portfolio of essential healthcare products including acute and chronic dialysis therapies, sterile intravenous (IV) solutions, infusion systems and devices, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. It operates through the following segments: Americas, Europe, Middle East and Africa (EMEA), Asia-Pacific (APAC), and Hillrom. The Americas, EMEA, and APAC segments offer a portfolio of essential healthcare products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices, and equipment for the surgical space. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

BAX
Baxter International Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BAX News

BAX Baxter International Inc.